BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36383629)

  • 61. Incidence, predictors, and clinical outcomes of early stent thrombosis in acute myocardial infarction patients treated with primary percutaneous coronary angioplasty (insights from the University of Ottawa Heart Institute STEMI registry).
    Singh K; Rashid M; So DY; Glover CA; Froeschl M; Hibbert B; Chong AY; Dick A; Labinaz M; Le May M
    Catheter Cardiovasc Interv; 2018 Apr; 91(5):842-848. PubMed ID: 28733995
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Predictors of mortality in patients with non-anterior ST-segment elevation myocardial infarction: Analysis from the HORIZONS-AMI trial.
    Huang X; Redfors B; Chen S; Gersh BJ; Mehran R; Zhang Y; McAndrew T; Ben-Yehuda O; Mintz GS; Stone GW
    Catheter Cardiovasc Interv; 2019 Aug; 94(2):172-180. PubMed ID: 30690854
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evaluation of neutrophil gelatinase-associated lipocalin and cystatin C as biomarkers of acute kidney injury after ST-segment elevation myocardial infarction treated by percutaneous coronary intervention.
    Nguyen LS; Spagnoli V; Kerneis M; Hauguel-Moreau M; Barthélémy O; Collet JP; Montalescot G; Silvain J
    Arch Cardiovasc Dis; 2019 Mar; 112(3):180-186. PubMed ID: 30639197
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparison of prognostic significance between serum fibrinogen and Global Registry of Acute Coronary Events score for prognosis of patients with non-ST-elevation acute coronary syndromes undergoing percutaneous coronary intervention.
    Song J; Yu T; Sun Z; Li Z; He D; Sun Z
    Coron Artery Dis; 2020 Mar; 31(2):124-129. PubMed ID: 31833946
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Accuracy of dedicated risk scores in patients undergoing primary percutaneous coronary intervention in daily clinical practice.
    Abelin AP; David RB; Gottschall CA; Quadros AS
    Can J Cardiol; 2014 Jan; 30(1):125-31. PubMed ID: 24238848
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Sex Differences Persist in Time to Presentation, Revascularization, and Mortality in Myocardial Infarction Treated With Percutaneous Coronary Intervention.
    Stehli J; Martin C; Brennan A; Dinh DT; Lefkovits J; Zaman S
    J Am Heart Assoc; 2019 May; 8(10):e012161. PubMed ID: 31092091
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical and Angiographic Predictors of Mortality in Sudden Cardiac Arrest Patients Having Cardiac Catheterisation: A Single Centre Registry.
    Xu J; Hee L; Hopkins A; Juergens CP; Lo S; French JK; Mussap CJ
    Heart Lung Circ; 2019 Mar; 28(3):370-378. PubMed ID: 29459218
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Impact of nutritional status on prognosis in acute myocardial infarction patients undergoing percutaneous coronary intervention.
    Kanda D; Ikeda Y; Takumi T; Tokushige A; Sonoda T; Arikawa R; Anzaki K; Kosedo I; Ohishi M
    BMC Cardiovasc Disord; 2022 Jan; 22(1):3. PubMed ID: 34996387
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Admission high-sensitivity C-reactive protein levels improve the Grace risk score prediction on in-hospital outcomes in acute myocardial infarction patients.
    Lin XL; Sun HX; Li FQ; Zhao JY; Zhao DH; Liu JH; Fan Q
    Clin Cardiol; 2022 Mar; 45(3):282-290. PubMed ID: 35066901
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Development and Validation of a Novel Risk Score for Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction.
    Andrews M; Iqbal J; Wall JJ; Teare D; El-Omar M; Fath-Ordoubadi F; Gunn J
    Cardiovasc Revasc Med; 2019 Nov; 20(11):980-984. PubMed ID: 30773426
    [TBL] [Abstract][Full Text] [Related]  

  • 71. GRACE risk score: Sex-based validity of in-hospital mortality prediction in Canadian patients with acute coronary syndrome.
    Gong IY; Goodman SG; Brieger D; Gale CP; Chew DP; Welsh RC; Huynh T; DeYoung JP; Baer C; Gyenes GT; Udell JA; Fox KAA; Yan AT;
    Int J Cardiol; 2017 Oct; 244():24-29. PubMed ID: 28645803
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Risk score comparison of outcomes in patients presenting with ST-elevation myocardial infarction treated with percutaneous coronary intervention.
    Scruth EA; Cheng E; Worrall-Carter L
    Eur J Cardiovasc Nurs; 2013 Aug; 12(4):330-6. PubMed ID: 22694809
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Measurement of left ventricular end-diastolic pressure improves the prognostic utility of the Global Registry of Acute Coronary Events score in patients with ST-segment elevation myocardial infarction.
    Watanabe I; Saito D; Noike R; Yabe T; Okubo R; Nakanishi R; Amano H; Toda M; Ikeda T
    AsiaIntervention; 2019 Jul; 5(2):134-140. PubMed ID: 36483524
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Ethnicity-dependent performance of the Global Registry of Acute Coronary Events risk score for prediction of non-ST-segment elevation myocardial infarction in-hospital mortality: nationwide cohort study.
    Moledina SM; Kontopantelis E; Wijeysundera HC; Banerjee S; Van Spall HGC; Gale CP; Shah BN; Mohamed MO; Weston C; Shoaib A; Mamas MA
    Eur Heart J; 2022 Jun; 43(24):2289-2299. PubMed ID: 35202472
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Clinical outcomes following ST-elevation myocardial infarction secondary to stent thrombosis treated by percutaneous coronary intervention.
    Noaman S; O'Brien J; Andrianopoulos N; Brennan AL; Dinh D; Reid C; Sharma A; Chan W; Clark D; Stub D; Biswas S; Freeman M; Ajani A; Yip T; Duffy SJ; Oqueli E;
    Catheter Cardiovasc Interv; 2020 Oct; 96(4):E406-E415. PubMed ID: 32087042
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Celık T; Balta S; Demır M; Yıldırım AO; Kaya MG; Ozturk C; Demırkol S; Unlu M; Kılıc S; Aydın İ; Iyısoy A
    Cardiol J; 2016; 23(1):84-92. PubMed ID: 26503078
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Predictors of no-reflow phenomenon following percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Aggarwal P; Rekwal L; Sinha SK; Nath RK; Khanra D; Singh AP
    Ann Cardiol Angeiol (Paris); 2021 Jun; 70(3):136-142. PubMed ID: 33962782
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Coronary microcirculation dysfunction evaluated by myocardial contrast echocardiography predicts poor prognosis in patients with ST-segment elevation myocardial infarction after percutaneous coronary intervention.
    Wang L; Ma Y; Jin W; Zhu T; Wang J; Yu C; Zhang F; Jiang B
    BMC Cardiovasc Disord; 2022 Dec; 22(1):572. PubMed ID: 36577944
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Survival of patients undergoing rescue percutaneous coronary intervention: development and validation of a predictive tool.
    Burjonroppa SC; Varosy PD; Rao SV; Ou FS; Roe M; Peterson E; Singh M; Shunk KA
    JACC Cardiovasc Interv; 2011 Jan; 4(1):42-50. PubMed ID: 21251628
    [TBL] [Abstract][Full Text] [Related]  

  • 80. B-type Natriuretic Peptide and RISK-PCI Score in the Risk Assessment in Patients with STEMI Treated by Primary Percutaneous Coronary Intervention.
    Asanin M; Mrdovic I; Savic L; Matic D; Krljanac G; Vukcevic V; Orlic D; Stankovic G; Marinkovic J; Stankovic S
    Clin Lab; 2016; 62(3):317-25. PubMed ID: 27156319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.